Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US
Awakn Provides Business Update on Progressing its Lead Program from Phase II b to Phase III Toronto, Ontario--(Newsfile Corp. - July 5,...
Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US
Bloom Health Partners Reports Profitable Fiscal Q2 2022 with $11.1 Million in Revenue
PODA Announces Multiparty Sale of Intellectual Property Assets for US$100.5 Million
Numinus To Acquire Novamind For A Total Of $26.2 Million
Core One Labs To Investigate Soliciting Investment And Potential Takeover Opportunities
Decibel Grants Options To Buy 3.47 Million Shares
C21 Investments Sells Some Oregon Assets For $2M (U.S.)